insurance companies that cover glp-1 drugs scrambling to support need for - The C.O.R.E. Group □ Understanding GLP-1 Medications &
Description
Indication expansion, such as approvals for additional metabolic and cardiovascular conditions, is broadening patient access and driving adoption
IntroductionWith the rise in glucagon-like peptide 1 receptor agonist (GLP-1RA) medication usage for Type 2 diabetes mellitus and weight loss, concerns have ...
In a recent Managed Healthcare Executive pharmacy survey, plan sponsors, []
Discover Now!
In crude analyses, GLP-1 receptor agonist use was associated with an increased incidence of suicidality compared with DPP-4 inhibitors (crude incidence rates 3.9 v 1.8 per 1000 person years, respectively
